Douglas A Treco Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas A Treco.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas A Treco. Douglas A Treco is a President and CEO in Ra Pharmaceuticals, Inc. ($RARX) and a Director in CRISPR Therapeutics AG ($CRSP) and a Director in Inozyme Pharma, Inc. ($INZY).
Address: C/O RA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE 02140 MA
Companies in which Douglas A Treco is an Insider
CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Douglas A Treco: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2020
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Inozyme Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas A Treco: Director
Holdings: 0 shares
Latest Transaction: Jul 24 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ra Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas A Treco: President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Douglas A Treco
Sentiment: All, CRSP, INZY, RARX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Treco Douglas A | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Treco Douglas A | Director | Option Exercise | A | 16.00 | 9,367 | 149,872 | 9,367 | |
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Treco Douglas A | Director | Option Exercise | A | 59.70 | 30,000 | 1,791,000 | 30,000 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 0.00 | 20,833 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 21.00 | 311,000 | 6,531,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 7.33 | 125,000 | 916,250 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 16.64 | 225,000 | 3,744,000 | 0 |